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Introduction: Myxomas are the most common benign tumors of the heart. They vary widely in size, and little is
known about their growth rate. The present case report is, we believe the first in bibliography that provides images
of an apical left ventricular myxoma from transthoracic echocardiography and computed tomography scans taken a
year apart.
Case presentation: We present the rare case of a 65-year-old asymptomatic Caucasian man with an apical left
ventricular myxoma that grew over a 12-month period. Our patient underwent successful surgical excision of the
tumor and had an uneventful postsurgical recovery period.
Conclusions: Left ventricular myxomas are benign and curable tumors. They do not usually present with systemic
symptomatology and most of them are diagnosed as sequelae of syncope caused by left ventricular outflow tract
obstruction or systemic embolization. Because they are usually removed after diagnosis, the growth rate of
myxomas is generally unknown. We present a rare case of the asymptomatic presentation of a left ventricular
myxoma and its documented growth during a 12-month period.Introduction
Left ventricular (LV) myxomas are more common in
women and may arise from any region of the left ventricle,
in contrast to atrial myxomas, which usually originate
from the interatrial septum. Whereas atrial myxomas are
usually associated with symptoms and signs of systemic ill-
ness (weight loss, fatigue, fever, anemia, leukocytosis) [1],
these symptoms are usually not observed in patients with
ventricular myxomas. Although the number of asymptom-
atic cardiac tumors being detected has increased due to
the widespread use of echocardiography, left ventricular
myxomas are still rare and the diagnosis is often preceded
by syncope caused by left ventricular outflow tract ob-
struction or systemic embolization. From 1957 to present,
98 cases of LV myxoma have been reported [2]. A case* Correspondence: giotadoc@gmail.com
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distribution, and reproduction in any mediumreport described by Artel et al. [1] demonstrated that LV
myxomas can grow, with a rate of increasing volume and
diameter that is similar to that of atrial myxomas.
The exact etiology of myxomas is unknown and most
cases are sporadic. Familial atrial myxomas have an
autosomal-dominant transmission, but these account
for <10% of the total. Although familial myxomas may
be transmitted without any associated disorders, they
may present as a component of a Carney complex, an
autosomal-dominant condition comprising myxomas at
various sites, endocrine tumors, and spotty pigmenta-
tion of the skin. It is well accepted that myxomas can
develop after cardiac trauma and that radiofrequency
ablation for paroxysmal atrial fibrillation (PAF) increases
the risk of thrombus or endocarditis in the atrium [3,4].
Because myxomas are usually removed once the diag-
nosis is made, their growth rate is generally unknown.
The reported growth rates of left atrial myxomas from
previous reports vary from no growth to between 1.3 totral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
a b
Figure 1 Transthoracic echocardiography. Apical two-chamber view in (a) systole and (b) diastole. A large pedunculated mass located at the
apical interventricular septum is seen (arrows). V is a marker which shows where the transducer is.
Kourkoveli et al. Journal of Medical Case Reports 2014, 8:60 Page 2 of 5
http://www.jmedicalcasereports.com/content/8/1/606.9mm/month in diameter [5,6]. These estimated growth
rates are primarily assumed to be based on linear growth
and have been calculated from echocardiography images
in case reports of patients with left atrial myxomas that
were found either accidentally or after the onset of
symptoms and already had echocardiographic follow-up
for other reasons.
Although recurrence has been reported, LV myxomas
are usually benign and curable [7-9]. The overall recur-
rence rate of resected myxomas is very low and increases
linearly during the first four years after resection. Evidence
suggests that recurrence is related to age, positive family
history, multifocal localization and to the method of surgi-
cal excision [9]. To prevent recurrence, it is necessary to
select the best surgical approach that enables adequate
visualization of the myxoma and its stalk, and to resect
the tumor and underlying myocardium en masse.
The surgical approach to ventricular myxomas tends to
be site-specific and efforts have been made to improve
procedural outcomes and minimize the potential postop-
erative complications [10]. Minimally invasive excisions asa b
Figure 2 Transthoracic echocardiography. Apical two-chamber view in
from 12 months previously. V is a marker which shows where the transducwell as atrial and aortic approaches have been successfully
used depending on tumor topography. In our patient, ven-
triculotomy was chosen as the optimal surgical approach
after taking into consideration the tumor’s location.Case presentation
A 65-year-old Caucasian man with a history of PAF was
referred to our hospital for further evaluation of a mass
located in the apex of his left ventricle. The mass was
discovered incidentally after a transthoracic echocardio-
graphic (TTE) examination during hospitalization for
paroxysmal atrial fibrillation.
Our patient’s medical history was unremarkable apart
from an unsuccessful pulmonary vein ablation for PAF,
which took place 12 months previously. On admission,
our patient had a heart rate of 80 beats/minute in sinus
rhythm, blood pressure of 130/68mmHg, normal carotid
pulse, and absence of murmurs or extra-cardiac sounds.
A physical examination was normal and our patient was
asymptomatic.(a) systole and (b) diastole. No evidence of mass is seen in this view
er is.
a b
Figure 3 Computed tomography. (a) Two-chamber and (b) four-chamber axial view images revealing a nodular mass at the apical
interventricular septum of the left ventricle. R indicates Right, A anterior and F Foot.
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a large, pedunculated, mobile mass sized 15 × 18mm
located at the apical interventricular septum of his left
ventricle, with a normally contracting adjacent myo-
cardium (Figure 1a,b). His left ventricular systolic
function and the morphology and function of his car-
diac valves were normal. His previous TTE performed
12 months previously at the same laboratory and by
the same sonographer did not demonstrate any left
ventricular mass (Figure 2a,b). Further evaluation with
cardiac computed tomography (CT) confirmed the pre-
sence of a nodular pedunculated mass (14 × 10mm) with
radiographic evidence of myxoma (Figure 3a,b) that wasa
Figure 4 Computed tomography. (a) Two-chamber and (b) four-chambe
attendance. No mass is seen. R indicates Right, A anterior and F Foot.not evident in the examination performed 12 months
earlier (Figure 4a,b). The previous TTE and chest CT
were performed before our patient underwent pulmon-
ary vein ablation. Magnetic resonance imaging showed
a nodular mass of 15mm with a 5mm stalk located at
the anterior apical segment of his intraventricular
septum. The intensity of the mass was higher than that
of the myocardium, with no signs of infiltration of the
endocardium.
Our patient underwent urgent cardiac surgery. Under
cardiopulmonary bypass and cardioplegic protection, a
left apical 2.5cm longitudinal ventriculotomy was per-
formed, which exposed the mass in full view (Figure 5).b
r axial view images performed 12 months prior to clinical
Figure 7 Histopathology of the excised mass shows myxoid
stroma containing single and small groups of lepidic cells and
a few small vessels.
Figure 5 Intraoperative photo showing the mass through an
apical left ventriculotomy.
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with felt strips (Figure 6).
Resection of the tumor was performed through the
ventriculotomy with macroscopically uninvolved mar-
gins. A pathology examination demonstrated the typical
features of a myxoma (Figure 7). Apart from two self-
terminated episodes of PAF, our patient had an unevent-
ful postoperative course and was discharged eight days
after the procedure.
Echocardiographic follow-up has not shown evidence
of recurrence eight months after the resection of the
myxoma.
Conclusion
Our case represents an unusual location of a cardiac
myxoma. Only three cases of apical left ventricular myx-
oma have been published [1,7,8] and, to the best of ourFigure 6 Intraoperative photo of the defect closure.knowledge, this is the first case providing images of an
apical left ventricular myxoma from TTE and CT scans
obtained a year apart, with an estimated growth rate of
1.2mm/month. No correlation can be found between the
radiofrequency ablation of the pulmonary valves that our
patient had undergone 12 months prior to the diagnosis
and the formation of the myxoma.
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